X @Bloomberg
Workforce Reduction - Novo is reducing its workforce by 11% [1] Market Strategy - Novo aims to accelerate its efforts to compete with Eli Lilly in the obesity market [1] - The company may adopt strategies similar to its US rival to achieve its goals [1]